Given that the upregulation of CTBP1-AS2 expression was able to suppress high glucose-induced inflammation in diabetic nephropathy in an in vitro study [31], it would be valuable to look into whether ErL targets inflammaging in DP via this long non-coding RNA, as well as its interplay with other microRNAs. This evidence concerns the gene CTBP1 and diabetic kidney disease.